Blue Water Vaccines, Inc. – NASDAQ:BWV
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 2 days
Blue Water Vaccines stock price monthly change
-43.92%
month
Blue Water Vaccines stock price quarterly change
-67.93%
quarter
Blue Water Vaccines stock price yearly change
-84.61%
year
Blue Water Vaccines key metrics
Market Cap | 3.40M |
Enterprise value | N/A |
P/E | -0.96 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | 0.55 |
PEG ratio | N/A |
EPS | -1.18 |
Revenue | N/A |
EBITDA | -13.75M |
Income | -18.21M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeBlue Water Vaccines stock price history
Blue Water Vaccines stock forecast
Blue Water Vaccines financial statements
| Dec 2022 | 0 | -3.16M | |
|---|---|---|---|
| Mar 2023 | 0 | -2.84M | |
| Jun 2023 | 0 | -6.86M | |
| Sep 2023 | 0 | -5.34M |
| 2025 | 0 | -20.24M |
|---|
Analysts Price target
Financials & Ratios estimates
| 2023-10-02 | -0.12 | -0.36 |
|---|---|---|
| 2023-11-17 | -0.19 | -0.28 |
| Dec 2022 | 26310447 | 3.92M | 14.91% |
|---|---|---|---|
| Mar 2023 | 22502101 | 2.80M | 12.48% |
| Jun 2023 | 29747515 | 16.67M | 56.04% |
| Sep 2023 | 27881871 | 17.64M | 63.29% |
| Dec 2022 | -2.80M | 5.19K | -582.83K |
|---|---|---|---|
| Mar 2023 | -4.44M | -1.81K | -48.95K |
| Jun 2023 | -1.78M | -10.03M | -214.66K |
| Sep 2023 | -3.04M | 173.01K | 1.29M |
Blue Water Vaccines alternative data
| Aug 2023 | 12 |
|---|---|
| Sep 2023 | 12 |
| Oct 2023 | 12 |
| Nov 2023 | 12 |
| Dec 2023 | 12 |
| Jan 2024 | 12 |
| Feb 2024 | 12 |
| Mar 2024 | 12 |
| Apr 2024 | 12 |
| May 2024 | 12 |
| Jun 2024 | 12 |
| Jul 2024 | 12 |
Blue Water Vaccines other data
8.90%
-4.61%
of BWV is owned by hedge funds
1.09M
-844.47K
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Aug 2022 | 0 | 554483 |
-
When is Blue Water Vaccines's next earnings date?
Unfortunately, Blue Water Vaccines's (BWV) next earnings date is currently unknown.
-
Does Blue Water Vaccines pay dividends?
No, Blue Water Vaccines does not pay dividends.
-
How much money does Blue Water Vaccines make?
Blue Water Vaccines has a market capitalization of 3.40M. Blue Water Vaccines made a loss 13.29M US dollars in net income (profit) last year or -$0.28 on an earnings per share basis.
-
What is Blue Water Vaccines's stock symbol?
Blue Water Vaccines, Inc. is traded on the NASDAQ under the ticker symbol "BWV".
-
What is Blue Water Vaccines's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Blue Water Vaccines?
Shares of Blue Water Vaccines can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Blue Water Vaccines have?
As Jul 2024, Blue Water Vaccines employs 12 workers.
-
When Blue Water Vaccines went public?
Blue Water Vaccines, Inc. is publicly traded company for more then 3 years since IPO on 18 Feb 2022.
-
What is Blue Water Vaccines's official website?
The official website for Blue Water Vaccines is bluewatervaccines.com.
-
Where are Blue Water Vaccines's headquarters?
Blue Water Vaccines is headquartered at 201 East Fifth Street, Cincinnati, OH.
-
How can i contact Blue Water Vaccines?
Blue Water Vaccines's mailing address is 201 East Fifth Street, Cincinnati, OH and company can be reached via phone at +51 36204101.
Blue Water Vaccines company profile:
Blue Water Vaccines, Inc.
bluewatervaccines.comExchange:
NASDAQ
Full time employees:
12
Industry:
Biotechnology
Sector:
Healthcare
Blue Water Vaccines, Inc., a biotechnology company, engages in the research and development of vaccines to prevent infectious diseases worldwide. The company's lead vaccine programs that are under preclinical development include BWV-101, an influenza vaccine; and BWV-102, a H1 pre-pandemic vaccine. It also has other pipeline under preclinical development comprising BWV-201, a streptococcus pneumoniae induced acute otitis media vaccine program; BWV-301, a norovirus-rotavirus vaccine program; and BWV-302, a norovirus-malaria vaccine program. The company was incorporated in 2018 and is based in Cincinnati, Ohio.
201 East Fifth Street
Cincinnati, OH 45202
Cincinnati, OH 45202
CIK: 0001782107
ISIN: US09610B1089
CUSIP: 09610B108
